Trump Reclassifies Marijuana to Schedule 3, Easing Research Restrictions

Major Shift in US Drug Policy

• ⚡ President Trump signed an executive order reclassifying cannabis from Schedule 1 to Schedule 3.
• 💡 This significant policy change, the biggest in over 50 years, aims to ease restrictions on marijuana for medical research.
• 🎯 The order allows for easier study of potential benefits, dangers, and future treatments, but does not legalize recreational use.

Impact on the Cannabis Industry

• 🚀 Industry experts anticipate this move will significantly benefit the legal cannabis business.
• 💰 Potential benefits include new tax deductions and banking access for legal operators.
• 📈 Some speculate it could attract big pharma into the cannabis market.

Federal Action and State Precedent

• 🧩 The reclassification aligns federal policy closer to actions taken by dozens of states that have approved marijuana for medical and recreational use.
• 📊 Public support for marijuana legalization has grown substantially, with 64% approval in recent Gallup polling.

Opposition and Concerns

• ⚠️ Despite the shift, there is heated division on the topic, even within the Republican party.
• 🗣️ Nearly half of the Senate Republican conference sent a letter opposing the change, citing marijuana's high potential for abuse.
• 🧠 Concerns were raised about marijuana's long-term effects on brain health, including potential permanent IQ loss in young users.